BGPT: Author Review: Kei Takahashi-Yamashiro

Explore by Goal

Quick Explanation Copied

Kei Takahashi-Yamashiro scientific footprint (evidence-limited to the records provided)

Based on the supplied OpenAlex author-match records and top works, the strongest “signal” comes from high-impact, mechanisms-focused primary research where Kei Takahashi appears as a co-author (e.g., influenza virus characterization, Ebola entry), plus additional biomedical topics (tissue clearing chemistry, cancer metastasis profiling, phylogenetic inference pitfalls, and apoptosis regulation). Evidence examples include 10.1038/nature08260 and 10.1371/journal.ppat.1001121.

Caveat: the provided dataset mixes “Kei Takahashi” and “Kei Takahashi-Yamashiro” name variants, and it does not include the full paper list for the exact “Kei Takahashi-Yamashiro” identity—so conclusions about the specific individual are lower-confidence than conclusions about the listed works.

Long Explanation

Author Review (skeptical, evidence-based): Kei Takahashi-Yamashiro

Visual evidence is derived only from the paper metadata/DOIs included in the prompt’s OpenAlex extract; no additional claims are made beyond those records.

1) Credible evidence anchors (from the provided record)

Influenza virology (swine-origin H1N1) — high citation anchor: 10.1038/nature08260 (Nature, 2009; “In vitro and in vivo characterization…”).
Ebola virus entry mechanism (glycoprotein-dependent internalization via macropinocytosis): 10.1371/journal.ppat.1001121 (PLoS Pathogens, 2010).
Tissue clearing chemistry (hydrophilic chemical landscape; >1,600 chemicals screened): 10.1016/j.celrep.2018.07.056 (Cell Reports, 2018).
Cancer metastasis whole-body profiling (single-cell resolution): 10.1016/j.celrep.2017.06.010 (Cell Reports, 2017).
Phylogenetic inference methodology (optimization principle pitfalls with small datasets): 10.1073/pnas.95.21.12390 (PNAS, 1998).
Apoptosis regulation in lymphoid cells (bcl-2 vs Fas antigen expression in lymphocytes): 10.1182/blood.v83.7.1856.1856 (Blood, 1994).
In vivo/molecular cancer inflammation programs (ZEB1-regulated inflammatory phenotype): 10.1002/1878-0261.12098 (Molecular Oncology, 2017).

2) Quantitative visibility from the provided OpenAlex extract (visualized)

The plots below use only the counts_by_year, works_count, and cited_by_count values embedded in the prompt’s OpenAlex JSON extract. These are bibliometric signals (not direct proof of rigor).

Interpretation guardrails: bibliometric counts can be inflated/deflated by field size, co-authorship patterns, or citation practices; they do not guarantee reproducibility.

3) Mechanistic breadth from the provided works list

This section evaluates scientific “shape” (what kinds of questions are being tackled) using only the paper titles/DOIs shown in the prompt.

Topic area (from title/venue)	Paper (DOI)	What the record explicitly indicates	Evidence-strength cue (title-level only)
Virology / influenza characterization	10.1038/nature08260 (Nature, 2009)	“In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses” (title-level)	Moderate (impact venue + mechanism/empirics implied by title, but full methods not provided here)
Viral entry mechanism / cell biology	10.1371/journal.ppat.1001121 (PLoS Pathogens, 2010)	“Ebolavirus Is Internalized into Host Cells via Macropinocytosis…” (title-level mechanism claim)	Moderate (mechanistic framing; rigorous evidence depends on experimental details not included in prompt)
Biomedical optics chemistry / tissue clearing	10.1016/j.celrep.2018.07.056 (Cell Reports, 2018)	“Hydrophilic chemical cocktails…” and “More than 1,600 chemicals were screened…” (title/abstract snippet in prompt record)	Moderate (high-throughput implied; reproducibility requires protocols and validation not fully shown here)
Computational/experimental cancer profiling	10.1016/j.celrep.2017.06.010 (Cell Reports, 2017)	“Whole-Body Profiling of Cancer Metastasis with Single-Cell Resolution” (title-level approach)	Moderate (single-cell + whole-body suggests complex validation, but details not available here)
Phylogenetics methodology / inference theory	10.1073/pnas.95.21.12390 (PNAS, 1998)	“Optimization principle… tends to give incorrect topologies when… small” (explicit cautionary methodological result)	Strong (if result holds generally; but full assumptions/dataset scope not provided here)
Immunology / apoptosis regulation	10.1182/blood.v83.7.1856.1856 (Blood, 1994)	“bcl-2 protein and Fas antigen… in lymphoblasts… and activated… T and B lymphocytes” (title-level measurement)	Moderate (biological measurements implied; full experimental design not available here)
Cancer transcriptional programs / inflammation	10.1002/1878-0261.12098 (Molecular Oncology, 2017)	“ZEB1-regulated inflammatory phenotype…” (title-level regulatory/inflammatory claim)	Moderate

4) Scientific strength assessment (what can be inferred vs what remains unknown)

What looks strong in the provided record

Mechanistic orientation across domains: Multiple provided works emphasize mechanistic biology (viral entry/internalization; apoptotic regulation; transcriptional inflammatory phenotype) rather than purely descriptive correlational studies—however, full experimental details are not included in the prompt.
Methodological self-correction emphasis in one anchor: The PNAS phylogenetics paper explicitly addresses failure modes of inference methods under small alignment sizes (a form of epistemic humility baked into the methodology).
High-throughput / complex experimental design implied by titles: The tissue-clearing chemistry anchor explicitly mentions screening “more than 1,600 chemicals,” suggesting scale and combinatorial chemistry evaluation.

Major uncertainty / potential mis-attribution risk

Name disambiguation: The prompt includes OpenAlex entries for both “Kei Takahashi” and “Kei Takahashi-Yamashiro,” but the cited DOI anchors appear under the “Kei Takahashi” record in the provided extract. Without the exact paper list for “Kei Takahashi-Yamashiro” identity, attributing specific mechanistic claims to the exact individual is lower confidence.
Co-authorship ambiguity: Most listed works show the author as a co-author (not necessarily first/last). Scientific rigor and contribution can vary widely by author position; the prompt does not include author contribution statements.
Raw-data access limitation: BGPT’s philosophy is raw full-text grounding, but the prompt provides only metadata snippets and DOIs, not full experimental raw data.

What would most change this review: the exact publication list tied to “Kei Takahashi-Yamashiro” (not name variants), plus the author’s specific contributions and whether key results replicate across independent batches/labs.

5) Evidence snippets (direct from titles/abstract snippets in the provided extract)

Ebola internalization route

The provided record states that Ebola virus internalization into host cells occurs via macropinocytosis in a viral glycoprotein-dependent manner.

Influenza characterization in vitro and in vivo

The provided record describes “in vitro and in vivo characterization” of new swine-origin H1N1 influenza viruses.

Tissue clearing chemistry landscape

The record indicates development of hydrophilic chemical cocktails based on comprehensive chemical profiling and explicit high-throughput screening scale (>1,600 chemicals).

Cancer metastasis profiling at single-cell resolution

The record positions the work as “Whole-Body Profiling of Cancer Metastasis with Single-Cell Resolution,” implying spatially distributed detection/profiling with single-cell granularity.

6) Suggested next BGPT actions (to strengthen attribution + rigor review)

Feedback:

Updated: March 26, 2026